The high mortality rate in Sub-Saharan Africa is mainly caused by Malaria. Millions of cases are recorded yearly in Nigeria, particularly involving the high risk/vulnerable groups (Pregnant, Children, Expatriates & Immunocompromised).
At Charterhouse Pharmaceutics, we will continue to encourage preventative measures to reduce and ultimately halt the spread of Malaria in Nigeria and Sub-Saharan Africa.
If diagnosed with uncomplicated Malaria, Charterhouse Pharmaceutics has the required treatment for you.
Find out more on how to treat Malaria with our range of treatment for Malaria.